Loading organizations...
Loading organizations...
SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on two broad areas. The first is revolutionary deep technology that promises the betterment of humanity and the planet. The second is cross-border markets, notably in Asia, that are ripe for explosive growth. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, series A, and later rounds while providing founders with ongoing support and community.
Key people at SOSV.
SOSV is a global venture capital firm specializing in early-stage investments in revolutionary deep tech startups, particularly those focused on human and planetary health. Its mission is to accelerate startups through intensive development programs and ongoing support, enabling them to go further, faster. SOSV’s investment philosophy centers on backing transformative technologies in sectors such as hard tech, life sciences, climate tech, and cross-border markets, especially in Asia. The firm operates flagship accelerator programs like HAX (hard tech) and IndieBio (life sciences), providing startups with funding, state-of-the-art labs, and extensive networks. SOSV has a significant impact on the startup ecosystem by supporting over 1,000 companies globally, helping them raise billions in follow-on funding, and fostering diversity with founders from 75 nationalities and a strong representation of PhDs and female founders[1][2][3].
Founded in 1995 by Sean O'Sullivan, SOSV began as a small family office and evolved into a leading venture capital firm headquartered in Princeton, New Jersey, with offices in key innovation hubs including New York City, Newark, San Francisco, Cork, Pune, Shenzhen, and Tokyo. Over time, SOSV sharpened its focus on deep tech and life sciences, launching specialized startup development programs such as HAX and IndieBio to provide hands-on support and resources. The firm’s growth included raising multiple funds, with its latest core fund closing at $306 million in 2024, and expanding its global footprint to support startups in emerging markets through programs like Orbit Startups[1][4][6].
SOSV rides the wave of increasing demand for deep tech solutions that address urgent global challenges such as climate change, sustainable production, and healthcare innovation. The timing is critical as technological advances in automation, biotechnology, and materials science converge with growing investor interest in impact-driven ventures. Market forces favor startups that can deliver scalable, sustainable solutions, and SOSV’s focus on human and planetary health aligns with these trends. By accelerating startups in Asia and cross-border markets, SOSV also taps into rapidly growing innovation ecosystems, influencing the global venture landscape by bridging early-stage capital with deep tech expertise[1][2][3].
Looking ahead, SOSV is poised to deepen its leadership in deep tech venture capital by expanding its accelerator programs and increasing fund sizes to support more startups globally. Trends such as climate tech innovation, synthetic biology, and automation will likely shape its portfolio focus. SOSV’s continued emphasis on diversity and cross-border collaboration will enhance its influence, helping to democratize access to capital and technology. As the firm scales, its integrated approach of funding plus hands-on development programs will remain a key differentiator, enabling startups to navigate complex technical and market challenges more effectively[3][4][6]. This positions SOSV not just as an investor but as a catalyst for transformative technologies that address some of the world’s most pressing problems.
Key people at SOSV.
